Nefopam Impurity 34 CAS CATO-C4X-283734
| CAS No. | CATO-C4X-283734 |
| Molecular Formula | C16H15NO2 |
| Molecular Weight | 253.30 g/mol |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
Chemical Structure
Description
Compared with other compounds in its class, the molecular weight of 253.30 g/mol gives Nefopam Impurity 34 distinctive chromatographic separation conditions and mass-spectrometry parameter settings.
CATO supplies Nefopam Impurity 34 (CAS CATO-C4X-283734), a pharmacopoeial impurity reference standard (molecular formula C16H15NO2, MW 253.30 g/mol) used for the identification and quantification of trace impurities in APIs.
The molecular framework of Nefopam Impurity 34 (C16H15NO2) is characterized by a nitrogen-containing heterocyclic scaffold, an amide group, a hydroxyl group, an ether linkage. In reversed-phase chromatography, its retention is governed primarily by its high hydrophobicity (logP), which provides a practical basis for HPLC-UV/DAD or LC-MS method development. The presence of an aromatic ring or conjugated system gives the compound characteristic absorption bands in the UV-Vis region, making it well suited to UV or diode-array detection (DAD).
This reference standard supports related-substances testing and method development in line with ICH Q3A/Q3B guidance on impurity control, and is suitable for system suitability testing and forced-degradation studies.
The assigned purity is verified by mass-balance and quantitative NMR (qNMR) approaches, with the expanded uncertainty reported at a 95% confidence level (k=2). Batch homogeneity and stability are independently assessed for every lot.
Physical & Chemical Properties
| Molecular Formula | C16H15NO2 |
| Molecular Weight | 253.30 g/mol |
| Appearance | Pale yellow to yellow crystalline powder |
| Purity | ≥95% |
| Storage | Store at 2-8°C, protect from light |
| Solubility (reference) | Soluble in chloroform, dichloromethane, ethyl acetate, DMSO |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light |
| Degree of Unsaturation (DBE) | 10.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| Nitrogen Atoms | 1 |
Related Nefopam Standards
Recommended Standards
- Varenicline Impurity 22 (CAS 1213781-59-9)
- 1-(3-Fluoro-4-((tetrahydro-2h-pyran-2-yl)methoxy)phenyl)ethan-1-amine (CAS 1019525-34-8)
- Esmolol Impurity 77 (CAS CATO-C4X-189177)
- 1,3-Di-tert-butyl-2-fluoro-5-nitrobenzene (CAS 10330-50-4)
- Paclitaxel Impurity 49 (CAS 2180123-01-5)
- Allisartan Isoproxil Impurity 12 (CAS CATO-C4X-321712)
- Ensitrelvir Impurity 1 (CAS 1360105-53-8)
- 2-[4-(1,2-oxazole-3-amido)phenyl]acetic acid (CAS 1285096-62-9)
- 2-(4-Bromo-2-isopropylphenyl)-1,3-dioxolane (CAS 2221812-09-3)
- 7-Methyl-6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidin-4-amine (CAS 1854-41-7)
- 2-(1-Chloroethyl)-5-(4-fluorophenyl)-1,3,4-oxadiazole (CAS 854137-54-5)
- 5-Bromo-2-chloro-4-ethynylpyridine (CAS 1823919-38-5)
- (S)-2-(4-Chloro-2-fluorophenyl)oxirane (CAS 2077956-38-6)
- Gastric Inhibitory Polypeptide (3-42) (human) trifluoroacetate salt (CAS 1802086-25-4)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com